Xilio Therapeutics Statistics

Total Valuation

XLO has a market cap or net worth of $34.97 million. The enterprise value is -$46.72 million.

Market Cap	34.97M
Enterprise Value	-46.72M

Important Dates

The next estimated earnings date is Thursday, August 7, 2025, before market open.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

XLO has 51.78 million shares outstanding. The number of shares has increased by 136.13% in one year.

Current Share Class	51.78M
Shares Outstanding	51.78M
Shares Change (YoY)	+136.13%
Shares Change (QoQ)	+15.50%
Owned by Insiders (%)	14.27%
Owned by Institutions (%)	17.05%
Float	24.90M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.78
Forward PS	1.54
PB Ratio	3.29
P/TBV Ratio	3.22
P/FCF Ratio	1.64
P/OCF Ratio	1.63
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.96, with a Debt / Equity ratio of 0.73.

Current Ratio	1.96
Quick Ratio	1.91
Debt / Equity	0.73
Debt / EBITDA	n/a
Debt / FCF	0.37
Interest Coverage	-569.57

Financial Efficiency

Return on equity (ROE) is -297.84% and return on invested capital (ROIC) is -133.57%.

Return on Equity (ROE)	-297.84%
Return on Assets (ROA)	-38.21%
Return on Invested Capital (ROIC)	-133.57%
Return on Capital Employed (ROCE)	-101.57%
Revenue Per Employee	$144,906
Profits Per Employee	-$848,484
Employee Count	64
Asset Turnover	0.10
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -25.96% in the last 52 weeks. The beta is 0.02, so XLO's price volatility has been lower than the market average.

Beta (5Y)	0.02
52-Week Price Change	-25.96%
50-Day Moving Average	0.77
200-Day Moving Average	0.87
Relative Strength Index (RSI)	44.17
Average Volume (20 Days)	967,400

Short Selling Information

The latest short interest is 2.62 million, so 5.07% of the outstanding shares have been sold short.

Short Interest	2.62M
Short Previous Month	791,482
Short % of Shares Out	5.07%
Short % of Float	10.54%
Short Ratio (days to cover)	1.03

Income Statement

In the last 12 months, XLO had revenue of $9.27 million and -$54.30 million in losses. Loss per share was -$0.83.

Revenue	9.27M
Gross Profit	9.27M
Operating Income	-56.96M
Pretax Income	-65.53M
Net Income	-54.30M
EBITDA	-55.26M
EBIT	-56.96M
Loss Per Share	-$0.83

Full Income Statement

Balance Sheet

The company has $89.07 million in cash and $7.86 million in debt, giving a net cash position of $81.21 million or $1.57 per share.

Cash & Cash Equivalents	89.07M
Total Debt	7.86M
Net Cash	81.21M
Net Cash Per Share	$1.57
Equity (Book Value)	10.70M
Book Value Per Share	0.21
Working Capital	45.56M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $21.10 million and capital expenditures -$58,000, giving a free cash flow of $21.04 million.

Operating Cash Flow	21.10M
Capital Expenditures	-58,000
Free Cash Flow	21.04M
FCF Per Share	$0.41

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-614.16%
Pretax Margin	-585.54%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	226.91%

Dividends & Yields

XLO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-136.13%
Shareholder Yield	-136.13%
Earnings Yield	-157.46%
FCF Yield	61.02%

Analyst Forecast

The average price target for XLO is $4.00, which is 492.33% higher than the current price. The consensus rating is "Buy".

Price Target	$4.00
Price Target Difference	492.33%
Analyst Consensus	Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	9.75%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

XLO has an Altman Z-Score of -6.29 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.29
Piotroski F-Score	2